Arrowhead Pharmaceuticals Inc.

NASDAQ:ARWR   3:59:19 PM EDT
67.95
-0.75 (-1.09%)
Earnings Announcements

Arrowhead Pharmaceuticals Reports Fiscal 2021 Q2 Results

Published: 05/04/2021 20:40 GMT
Arrowhead Pharmaceuticals Inc. (ARWR) - Arrowhead Pharmaceuticals Reports Fiscal 2021 Second Quarter Results.
Qtrly Revenue $32.8 Million Versus $23.5 Million.
Qtrly Loss per Share $0.26.
Q2 Revenue View $37.7 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $43.14 Million
Adjusted EPS is expected to be -$0.15

Next Quarter Revenue Guidance is expected to be $74.24 Million
Next Quarter EPS Guidance is expected to be -$0.25

More details on our Analysts Page.